Skip to content
— CH. 1 · FOUNDING AND EVOLUTION —

Alcohol: Clinical & Experimental Research

~2 min read · Ch. 1 of 5
5 sections
  • The journal began its life in 1977 under the name Alcoholism: Clinical and Experimental Research. It served as a dedicated space for scientific inquiry into alcohol abuse during that era. For over four decades, this title remained unchanged while the field of study expanded significantly. In 2023, editors officially adopted the current name Alcohol: Clinical & Experimental Research to reflect modern terminology. This shift marked a deliberate move away from older stigmatizing language toward more precise clinical descriptions. The change signaled an evolution in how researchers approach the subject matter within the medical community.

  • Wiley-Blackwell serves as the primary publisher responsible for distributing the journal globally. They operate on behalf of two major organizations: the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. These societies provide the editorial oversight necessary to maintain high scientific standards across all issues. Their collaboration ensures that peer review processes remain rigorous and aligned with professional guidelines. The partnership between the commercial publisher and these non-profit research groups creates a stable infrastructure for dissemination. This structure allows the publication to reach a wide audience of clinicians and scientists without compromising academic integrity.

  • Researchers rely on specific databases to locate articles published within this journal. Major platforms include MEDLINE, Scopus, and Embase among many others listed in official records. Additional indexes such as BIOSIS Previews and CAB HEALTH ensure broad coverage across biological and health sciences. The presence in Psychological Abstracts/PsycINFO connects alcohol studies directly to mental health literature. Science Citation Index and Current Contents further amplify visibility for international audiences. These aggregations mean that findings from the journal appear in search results used by hospitals, universities, and government agencies worldwide. Without inclusion in these systems, the work would struggle to reach its intended clinical and research communities.

  • The 2020 impact factor score reached 3.455 according to Journal Citation Reports data. This metric measures how frequently articles are cited relative to other journals in the same field. Within the category labeled Substance Abuse, the publication ranked 12th out of 21 competing titles. That position places it near the middle of the pack rather than at the very top or bottom. The score reflects consistent engagement with the material by other researchers over time. It indicates a steady flow of citations without explosive spikes in attention during that year. Such rankings help institutions evaluate the value of subscribing to the journal for their libraries.

  • Articles focus specifically on alcohol abuse and methods designed to treat the condition. The content covers experimental data gathered from laboratory settings alongside clinical observations from patient care environments. Researchers submit manuscripts detailing new therapies, behavioral interventions, and biological mechanisms underlying addiction. The scope excludes non-alcohol substances unless they directly relate to ethanol consumption patterns. Treatment methodologies range from pharmacological approaches to psychological counseling techniques documented in case studies. This narrow focus allows the editors to curate highly relevant information for professionals working directly with patients suffering from alcohol use disorders.

Common questions

When did Alcohol: Clinical & Experimental Research change its name from Alcoholism: Clinical and Experimental Research?

Editors officially adopted the current name Alcohol: Clinical & Experimental Research in 2023. This shift marked a deliberate move away from older stigmatizing language toward more precise clinical descriptions.

Which organizations publish Alcohol: Clinical & Experimental Research through Wiley-Blackwell?

Wiley-Blackwell serves as the primary publisher on behalf of the Research Society on Alcoholism and the International Society for Biomedical Research on Alcoholism. These societies provide the editorial oversight necessary to maintain high scientific standards across all issues.

What databases index articles published in Alcohol: Clinical & Experimental Research?

Major platforms include MEDLINE, Scopus, Embase, BIOSIS Previews, CAB HEALTH, Psychological Abstracts/PsycINFO, Science Citation Index, and Current Contents. The presence in these aggregations means that findings appear in search results used by hospitals, universities, and government agencies worldwide.

How was the impact factor score for Alcohol: Clinical & Experimental Research ranked in 2020?

The 2020 impact factor score reached 3.455 according to Journal Citation Reports data. Within the category labeled Substance Abuse, the publication ranked 12th out of 21 competing titles.

What specific topics do articles in Alcohol: Clinical & Experimental Research cover regarding alcohol abuse?

Articles focus specifically on alcohol abuse and methods designed to treat the condition including experimental data from laboratory settings and clinical observations from patient care environments. The scope excludes non-alcohol substances unless they directly relate to ethanol consumption patterns.